Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of human peripheral blood mononuclear cells before and after vaccination with human papilloma virus-like particle
Human papilloma (HPV) virus-like particle (VLP) vaccines were recently licensed. Though neutralizing antibody titers are thought to be the main effectors of protection against infection, early predictors of long-term efficacy are not yet defined and a comprehensive understanding of innate and adapt...
ORGANISM(S): Homo sapiens 
2008-11-22 | E-GEOD-13587 | biostudies-arrayexpress
ProteomicsPlant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
A growing body of evidence supports the importance of T cell responses to protect against severe influenza, promote viral clearance and ensure long-term immunity. Plant-derived virus-like particle (VLP) vaccines bearing influenza hemagglutinin (HA) have been shown to elicit strong humoral and CD4+ T...
ORGANISM(S): Homo sapiens (Human) 
2019-05-28 | PXD010519 | Pride
Influenza Cell-mediated immunity Cross-presentation Major histocompatibility complex class i Human monocyte-derived macrophage High-resolution mass spectrometry Plant-derived vaccine Virus-like particle 
UnknownAn Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Not available
S-EPMC5686733 | biostudies-literature
UnknownDevelopment of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.
Not available
S-EPMC5498722 | biostudies-literature
GenomicsCOVID-19 patient nasopharyngeal samples and SARS-CoV-2 Virus-Like-Particle (VLP)
Transcriptome analysis of COVID-19 patient nasopharyngeal samples and SARS-CoV-2 Virus-Like-Particle (VLP) infected cells
PRJEB57869 | ENA
UnknownZika virus-like particle (VLP) based vaccine.
Not available
S-EPMC5436897 | biostudies-literature
UnknownVirus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Not available
S-EPMC10454695 | biostudies-literature
GenomicsImmunogenicity and protective efficacy of Marburg virus glycoprotein and virus-like particle-forming mRNA-based vaccines.
Immunogenicity and protective efficacy of Marburg virus glycoprotein and virus-like particle-forming mRNA-based vaccines.
PRJNA1268395 | ENA
UnknownVLP-factory™ and ADDomer© : Self-assembling Virus-Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display.
Not available
S-EPMC9733710 | biostudies-literature
TranscriptomicsImmunogenicity and protective efficacy of Marburg virus glycoprotein and virus-like particle-forming mRNA-based vaccines.
Mounting evidence suggests the high immunogenicity of virus-like particle (VLPs) based vaccines. Although VLP vaccines can be effective, they have not been compared to an envelope glycoprotein (GP)-only vaccine for filoviruses. We conducted a detailed side-by-side comparison of the immunogenicity an...
ORGANISM(S): Cavia porcellus 
2025-06-27 | GSE298124 | GEO
Sort   by:  
 Page size